12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Loading...
Loading...

Gainers

  • FibroGen FGEN shares rose 37.1% to $1.59 during Tuesday's pre-market session. The market value of their outstanding shares is at $158.1 million. The company's, Q1 earnings came out yesterday.
  • Envoy Medical COCH stock moved upwards by 23.54% to $4.25. The company's market cap stands at $83.2 million.
  • iSpecimen ISPC shares rose 21.18% to $0.33. The company's market cap stands at $3.0 million. The company's, Q1 earnings came out today.
  • NovaBay Pharmaceuticals NBY shares moved upwards by 20.87% to $0.11. The company's market cap stands at $3.9 million.
  • GT Biopharma GTBP shares rose 19.25% to $3.84. The market value of their outstanding shares is at $5.3 million.
  • Esperion Therapeutics ESPR stock increased by 18.39% to $2.51. The company's market cap stands at $475.3 million. As per the news, the Q1 earnings report came out today.

Losers

  • Helius Medical Tech HSDT shares decreased by 16.5% to $2.02 during Tuesday's pre-market session. The company's market cap stands at $1.7 million.
  • Cellectis CLLS shares declined by 11.05% to $2.98. The company's market cap stands at $214.4 million.
  • Eledon Pharma ELDN shares fell 9.43% to $2.21. The market value of their outstanding shares is at $54.8 million.
  • Fresenius Medical Care FMS stock fell 8.03% to $19.7. The company's market cap stands at $11.5 billion.
  • Madrigal Pharmaceuticals MDGL shares declined by 7.42% to $218.1. The market value of their outstanding shares is at $4.6 billion. The company's, Q1 earnings came out today.
  • Context Therapeutics CNTX shares declined by 7.31% to $1.65. The company's market cap stands at $26.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...